These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 17159598

  • 21. Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.
    Candelaria M, Taja-Chayeb L, Arce-Salinas C, Vidal-Millan S, Serrano-Olvera A, Dueñas-Gonzalez A.
    Anticancer Drugs; 2005 Oct; 16(9):923-33. PubMed ID: 16162969
    [Abstract] [Full Text] [Related]

  • 22. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
    Ozawa S.
    Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
    [Abstract] [Full Text] [Related]

  • 23. Ethnic differences in drug metabolism and toxicity from chemotherapy.
    Phan VH, Moore MM, McLachlan AJ, Piquette-Miller M, Xu H, Clarke SJ.
    Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):243-57. PubMed ID: 19331590
    [Abstract] [Full Text] [Related]

  • 24. Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
    Quaranta S, Thomas F.
    Therapie; 2017 Apr; 72(2):205-215. PubMed ID: 28262261
    [Abstract] [Full Text] [Related]

  • 25. Pharmacogenetics and cancer chemotherapy.
    Iyer L, Ratain MJ.
    Eur J Cancer; 1998 Sep; 34(10):1493-9. PubMed ID: 9893619
    [Abstract] [Full Text] [Related]

  • 26. Introduction.
    Alex Sparreboom, Guest Editor, William D. Figg.
    Invest New Drugs; 2005 Dec; 23(6):511. PubMed ID: 16391895
    [No Abstract] [Full Text] [Related]

  • 27. Phenotyping drug disposition in oncology.
    Opdam FL, Gelderblom H, Guchelaar HJ.
    Cancer Treat Rev; 2012 Oct; 38(6):715-25. PubMed ID: 22226243
    [Abstract] [Full Text] [Related]

  • 28. Pharmacogenetics of chemotherapy efficacy in breast cancer.
    González-Neira A.
    Pharmacogenomics; 2012 Apr; 13(6):677-90. PubMed ID: 22515610
    [Abstract] [Full Text] [Related]

  • 29. [Pharmacogenomic data for personalized medicines].
    Yamazaki H.
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1886-90. PubMed ID: 16282721
    [Abstract] [Full Text] [Related]

  • 30. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J, Seeringer A, Brockmöller J.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cytochrome P450 pharmacogenetics and cancer.
    Rodriguez-Antona C, Ingelman-Sundberg M.
    Oncogene; 2006 Mar 13; 25(11):1679-91. PubMed ID: 16550168
    [Abstract] [Full Text] [Related]

  • 33. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD, Lee YB.
    Arch Pharm Res; 2011 Nov 13; 34(11):1817-28. PubMed ID: 22139683
    [Abstract] [Full Text] [Related]

  • 34. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S, Barreiro P, Jiménez-Nacher I, Rendón A, Soriano V.
    AIDS Rev; 2005 Nov 13; 7(2):103-12. PubMed ID: 16092504
    [Abstract] [Full Text] [Related]

  • 35. Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma.
    Hattinger CM, Serra M.
    Expert Opin Drug Metab Toxicol; 2015 Nov 13; 11(9):1449-63. PubMed ID: 26095223
    [Abstract] [Full Text] [Related]

  • 36. The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?
    Hesselink DA, van Gelder T, van Schaik RH.
    Pharmacogenomics; 2005 Jun 13; 6(4):323-37. PubMed ID: 16004552
    [Abstract] [Full Text] [Related]

  • 37. Germline pharmacogenetics of paclitaxel for cancer treatment.
    Hertz DL.
    Pharmacogenomics; 2013 Jul 13; 14(9):1065-84. PubMed ID: 23837481
    [Abstract] [Full Text] [Related]

  • 38. Enzymes and pharmacogenetics of cardiovascular drugs.
    Siest G, Jeannesson E, Visvikis-Siest S.
    Clin Chim Acta; 2007 May 13; 381(1):26-31. PubMed ID: 17362901
    [Abstract] [Full Text] [Related]

  • 39. Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.
    Dervieux T, Meshkin B, Neri B.
    Mutat Res; 2005 Jun 03; 573(1-2):180-94. PubMed ID: 15829247
    [Abstract] [Full Text] [Related]

  • 40. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
    Robaey P, Krajinovic M, Marcoux S, Moghrabi A.
    Dev Disabil Res Rev; 2008 Jun 03; 14(3):211-20. PubMed ID: 18924160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.